Shl Telemedicine

Shl Telemedicine, which was formed in 1987, has developed to become a significant provider of remote medical diagnostic and monitoring services. The company's solutions are intended to improve the quality of care, lower costs, and expand access to healthcare for people worldwide.

Healthcare practitioners, hospitals, and clinics all across the world use Shl Telemedicine's telemedicine services. The company's telemedicine solutions provide remote diagnosis, consultation, and treatment as well as real-time access to medical expertise. Shl Telemedicine's solutions are also employed in clinical trials and research investigations, where they provide remote monitoring and data collection.

Shl Telemedicine, in addition to its telemedicine solutions, provides medical devices and software platforms for remote monitoring of vital indicators such as blood pressure, glucose levels, and heart rate. Patients utilize these devices and platforms at home to communicate data to healthcare experts for remote monitoring and management.

Shl Telemedicine is a publicly traded company, and its financial information is available to the general public. According to the most current financial report, the company made $31.5 million in revenue in 2020, a 12% increase over the previous year. In 2020, the company made a net profit of $1.9 million, compared to a net loss of $3.1 million in 2019. As of August 2021, its market capitalization was roughly $70 million. Shl Telemedicine announced the fiscal year 2023 revenue of around $49.6 million.

Founded: 1987
Headquarters: 90 Yigal Alon, Tel Aviv, Tel Aviv, 67891, Israel
Website: https://www.shl-telemedicine.com/